冠状动脉旁路移植术中症状性晚期大隐静脉桥失败
基于瑞典SWEDEHEART注册数据,纳入1997至2020年间44 951例使用单支内乳动脉和1至3支大隐静脉桥的患者,分析术后临床驱动冠状动脉造影及桥血管状态。结果显示术后10年内每移植一支冠状动脉因静脉桥病变导致症状性桥失败的风险约为1-2%,为使用更优桥血管可能带来的改善上限提供了估计。
要点
- 术后10年内每支移植冠状动脉因静脉桥病变导致症状性桥失败的风险约为1-2%。
- 术后3年内临床驱动造影发生率分别为10.1%、7.9%和7.1%(对应1、2、3支静脉桥)。
- 术后10年内临床驱动造影发生率分别为23.6%、20.0%和17.5%(对应1、2、3支静脉桥)。
核心结论
- 结果提示术后10年内每移植一支冠状动脉因静脉桥病变导致症状性桥失败的风险约为1-2%,并为用更优桥血管替代大隐静脉桥可能达到的结果改善上限提供了估计。
研究设计与样本
- 从瑞典SWEDEHEART注册中筛选1997至2020年间手术、使用单支内乳动脉单远端吻合及1、2或3支大隐静脉桥远端吻合的患者,收集术后临床驱动冠状动脉造影及桥血管状态数据。
- 研究人群共44 951例患者。
主要发现
- 术后3年内临床驱动造影发生率分别为10.1%(95%CI 9.5-10.8)、7.9%(95%CI 7.6-8.3)和7.1%(95%CI 6.7-7.5),分别对应1、2、3支静脉桥患者。
- 术后10年内临床驱动造影发生率分别为23.6%(95%CI 22.6-24.5)、20.0%(95%CI 19.5-20.6)和17.5%(95%CI 16.9-18.2),分别对应1、2、3支静脉桥患者。
- 排除术后前3年,在术后10年内接受造影的病例中,分别有超过75%、60%和45%的病例未发现失败的大隐静脉桥,对应1、2、3支静脉桥患者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Coronary artery bypass grafting for advanced coronary artery disease is a well-established procedure with excellent long-term results. The issue of saphenous vein graft (SVG) performance and its relation to clinical symptoms and thereby the potential for improvement by using superior grafts are still not fully understood. We aim to estimate the contribution of late SVG failure to the long-term outcome. METHODS: A study population operated between 1997 and 2020, with an internal thoracic artery with a single distal anastomosis and 1, 2 or 3 distal SVG anastomoses, was isolated from the Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies registry. Data regarding postoperative clinically driven coronary angiography and status of bypass grafts were collected. RESULTS: The study population consisted of 44 951 patients. Clinically driven angiography occurred in 10.1% (9.5-10.8), 7.9% (7.6-8.3) and 7.1% (6.7-7.5), respectively, of patients within 3 years and 23.6% (22.6-24.5), 20.0% (19.5-20.6) and 17.5% (16.9-18.2), respectively, of patients within 10 years after surgery. Excluding the first 3 postoperative years, no failed SVGs were found in >75%, 60% and 45%, respectively, of cases when an angiography was performed in the first 10 years after surgery. CONCLUSIONS: The results suggest that the risk of symptomatic graft failure due to vein graft disease during the first 10 years after surgery is in the range of 1-2% for every grafted coronary vessel and provide an estimate for the upper limit of the improvements in results that could be achieved by replacing SVGs with superior grafts.
引用
- Janiec M, Dimberg A, Lindblom RPF, et al. Symptomatic late saphenous vein graft failure in coronary artery bypass surgery. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37014393. doi:10.1093/icvts/ivad052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。